We are live on ! Find out more
SIC

Samalin Investment Counsel Portfolio holdings

AUM $320M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+20.87%
3 Year Est. Return
+62.81%
5 Year Est. Return
+65.92%
10 Year Est. Return
AUM
$185M
AUM Growth
+$19.2M
Cap. Flow
+$12M
Cap. Flow %
6.51%
Top 10 Hldgs %
21.77%
Holding
296
New
34
Increased
139
Reduced
93
Closed
20

Sector Composition

Rank Sector Weight
1 Financials 9.37%
2 Technology 8.81%
3 Healthcare 7.35%
4 Real Estate 5.3%
5 Energy 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKSI icon
201
MKS Inc
MKSI
$20.9B
$268K 0.15%
2,483
+29
+1% +$2.65K
NLY icon
202
Annaly Capital Management
NLY
$17.1B
$267K 0.14%
13,331
+2,204
+20% +$42.8K
EPR icon
203
EPR Properties
EPR
$4.69B
$266K 0.14%
+5,681
New +$240K
F icon
204
Ford
F
$57.7B
$265K 0.14%
17,482
-577
-3% -$7.3K
NUE icon
205
Nucor
NUE
$58.9B
$264K 0.14%
1,609
+38
+2% +$5.55K
IIF
206
Morgan Stanley India Investment Fund
IIF
$218M
$262K 0.14%
12,081
-1,200
-9% -$24.3K
SKT icon
207
Tanger
SKT
$4.67B
$261K 0.14%
11,804
+351
+3% +$7.04K
TOTL icon
208
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.01B
$260K 0.14%
6,402
-7,930
-55% -$323K
HYD icon
209
VanEck High Yield Muni ETF
HYD
$4.42B
$259K 0.14%
5,052
-1,102
-18% -$56.5K
THW
210
abrdn World Healthcare Fund
THW
$540M
$259K 0.14%
18,440
+8,371
+83% +$119K
AWP
211
abrdn Global Premier Properties Fund
AWP
$369M
$258K 0.14%
21,898
+10,965
+100% +$128K
JPS
212
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$257K 0.14%
40,357
+19,530
+94% +$124K
PLD icon
213
Prologis
PLD
$134B
$254K 0.14%
2,073
+229
+12% +$28.2K
DFP
214
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$425M
$254K 0.14%
+14,582
New +$256K
BTO
215
John Hancock Financial Opportunities Fund
BTO
$806M
$251K 0.14%
+9,365
New +$253K
JEPQ icon
216
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$39.9B
$244K 0.13%
+5,042
New +$233K
C icon
217
Citigroup
C
$222B
$240K 0.13%
5,220
-962
-16% -$45.1K
IBB icon
218
iShares Biotechnology ETF
IBB
$9.18B
$240K 0.13%
1,887
-1
-0.1% -$130
HALO icon
219
Halozyme
HALO
$9.81B
$239K 0.13%
+6,637
New +$226K
XIFR
220
XPLR Infrastructure LP
XIFR
$1.11B
$236K 0.13%
+4,032
New +$242K
BHP icon
221
BHP
BHP
$212B
$236K 0.13%
3,959
-1,603
-29% -$95.6K
TFC icon
222
Truist Financial
TFC
$63B
$235K 0.13%
7,752
+996
+15% +$30.9K
AMT icon
223
American Tower
AMT
$80.4B
$233K 0.13%
1,201
-328
-21% -$64.1K
ACRE
224
Ares Commercial Real Estate
ACRE
$231M
$230K 0.12%
22,660
+8,510
+60% +$77.7K
REM icon
225
iShares Mortgage Real Estate ETF
REM
$538M
$230K 0.12%
9,726
-8,229
-46% -$180K

Similar funds

Samalin Investment Counsel's Q2 2023 Portfolio in Review

As of Q2 2023, Samalin Investment Counsel held 296 positions worth $185M, up 12% from $166M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Samalin Investment Counsel deployed $12M of net new capital in Q2 2023, opening 34 new positions and adding to 139 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 8,849 shares worth $910K.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $1.07M trimmed.

  • Samalin Investment Counsel's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 8,849 shares worth $910K.
  • Samalin Investment Counsel added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $1.43M increase.
  • Samalin Investment Counsel's biggest Q2 2023 reduction was Apple, cutting an estimated $1.07M.
  • Samalin Investment Counsel fully exited Magellan Midstream Partners, L.P. in Q2 2023, selling an estimated $1.03M.
  • Samalin Investment Counsel's ten largest holdings make up 22% of its $185M portfolio in Q2 2023.
  • Samalin Investment Counsel opened 34 new positions and closed 20 in Q2 2023.
  • Samalin Investment Counsel's portfolio value rose 12% quarter-over-quarter to $185M.

Based on Samalin Investment Counsel's 13F filing for Q2 2023, filed 3 Aug 2023.